Evaluation of the pilot program on the real-time drug utilization review system in South Korea
- Authors
- Heo, Ji Haeng; Suh, Dong Churl; Kim, Sukil; Lee, Eui-Kyung
- Issue Date
- Oct-2013
- Publisher
- ELSEVIER IRELAND LTD
- Keywords
- Drug utilization review; Inappropriate prescribing; Real-time system; Expenditures
- Citation
- INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, v.82, no.10, pp 987 - 995
- Pages
- 9
- Journal Title
- INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS
- Volume
- 82
- Number
- 10
- Start Page
- 987
- End Page
- 995
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/14243
- DOI
- 10.1016/j.ijmedinf.2013.07.001
- ISSN
- 1386-5056
1872-8243
- Abstract
- Purpose: A pilot drug utilization review (DUR) program was initiated by the Korean government, which provided safety information in real-time at the stage of prescribing and dispensing. This study aimed to compare the "physician/pharmacist Co-DUR" system and the traditional "pharmacist-only DUR" system. Methods: Data collected during a DUR pilot program from July 1 to October 31 of 2009 were obtained from the Health Insurance Review & Assessment Service. Descriptive analyses were conducted to investigate DUR-pop up alert rates, categories of alerts, the reasons for dispensing without prescription change after an alert, and changes in drug expenditures associated with the DUR. Results: DUR pop-up alert rates were 8.55% at clinics and 1.90% at pharmacies in the physician/pharmacist Co-DUR, whereas the rate was 2.22% in the pharmacist-only DUR. Rates of pop-up alerts were high for between-prescription ingredient duplication at pharmacies, whereas for clinics, the rate for drug-pregnancy contraindications was high. A greater reduction in drug expenditure was estimated in the physician/pharmacist Co-DUR compared to the pharmacist-only DUR. Conclusions: The physician/pharmacist Co-DUR has better sensitivity at detecting potential adverse drug events than the pharmacist-only DUR. Pharmacists also have opportunities to double-check prescribed drugs when doctors do not voluntarily modify pop-up alerts. Further comprehensive study will be needed to confirm the results of pilot program that favored the physician/pharmacist Co-DUR. (C) 2013 Published by Elsevier Ireland Ltd.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Pharmacy > School of Pharmacy > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/14243)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.